Table 2.

Distribution of patients according to malignancy type.

Parameters	Pre-lockdown (N = 4363)	During lockdown (N = 895)
Hematological malignancies	n = 881	n = 245
Leukemia
Acute lymphoblastic leukemia	280 (6.4)	95 (10.6)
Acute myeloblastic leukemia	66 (1.5)	25 (2.7)
Chronic myeloid leukemia	152 (3.5)	56 (6.3)
Chronic lymphocytic leukemia	13 (0.3)	3 (0.3)
Lymphoma
Non-Hodgkin lymphoma	110 (2.5)	24 (2.7)
Hodgkin lymphoma	55 (1.3)	9 (1.0)
Multiple myeloma	164 (3.8)	30 (3.3)
Myelodysplastic syndrome	14 (0.3)	1 (0.1)
Others	27 (0.6)	2 (0.2)

Data shown as n (%).